Philip Tsai

Equibles does not estimate personal net worth.

About Philip Tsai

Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.

Affiliation history

Immunome Inc. (IMNM)
Proxy statement

Current
Start not stated–present

Last confirmed April 24, 2026

Company network

Immunome Inc.

IMNM

Current role

Biotechnology · Healthcare

Leadership on record at Immunome Inc.

Clay B. Siegall, Ph.D. CEO
Clay Siegall CEO
Corleen Roche CFO
Diane Marcou CFO
Max Rosett CFO
Matthew K. Robinson CTO
Sandra Stoneman General Counsel
Bob Lapetina Chief Accounting Officer
Carol Schafer Board Member
Franklyn G. Prendergast, M.D., Ph.D. Board Member

Recent activity

No call appearances or filed executive changes recorded yet.